• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三年内老年急性冠状动脉综合征患者支架内再狭窄的预测价值分析:一项两中心回顾性研究。

Predictive Value Analysis of in-Stent Restenosis Within Three Years in Older Acute Coronary Syndrome Patients: A Two-Center Retrospective Study.

机构信息

Department of Cardiology, 442535The First People's Hospital of Taicang, The Affiliated Taicang Hospital of Soochow University, Taicang, China.

Department of Cardiology, 92323Zhongshan Hospital Affiliated of Fudan University, Shanghai, China.

出版信息

Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221107888. doi: 10.1177/10760296221107888.

DOI:10.1177/10760296221107888
PMID:35706375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9208031/
Abstract

We aimed to investigate prognostic factors of in-stent restenosis (ISR) within 3 years in older acute coronary syndrome (ACS) patients after drug-eluting stent (DES) implantation and establish a clinical model for predicting ISR. We retrospectively collected 215 older ACS patients who followed coronary angiography (CAG) after DES implantation, divided into ISR group and non in-stent restenosis (non-ISR) group according to the results of reviewed CAG. Logistic regression analysis was performed to screen independent predictors related to ISR and build the clinical predictive model, which clinical application was assessed by decision curve analysis (DCA) and clinical impact curve (CIC). Kaplan-Meier survival curves for ISR by independent predictors. In multivariate logistic regression analysis showed that the red cell distribution width (RDW) was higher in ISR group compared with non-ISR (odds ratio (OR) = 1.54, 95% confidence interval (CI): 1.14-2.08, p < 0.01). Instead, a negative correlation was observed between minimum stent diameter and ISR (OR = 0.28, 95%CI:0.09-0.86, p = 0.03). A novel nomogram composed of these significant features presented a concordance index (C-index) of 0.710, DCA and CIC suggested that the predictive nomogram had clinical utility. Schoenfeld residuals showed the model RDW ≥ 12.6% with minimum stent diameter <3 mm was consistent with the proportional risk assumption. The Kaplan-Meier estimate for ISR showed statistical significance. Higher levels of RDW and lower minimum stent diameter were associated with incidence of ISR within 3 years in older ACS patients after DES implantation.

摘要

我们旨在研究经药物洗脱支架 (DES) 植入后老年急性冠状动脉综合征 (ACS) 患者三年内支架内再狭窄 (ISR) 的预后因素,并建立预测 ISR 的临床模型。我们回顾性收集了 215 例经 DES 植入后接受冠状动脉造影 (CAG) 的老年 ACS 患者,根据 CAG 结果分为 ISR 组和非支架内再狭窄 (non-ISR) 组。采用 Logistic 回归分析筛选与 ISR 相关的独立预测因素,并建立临床预测模型,通过决策曲线分析 (DCA) 和临床影响曲线 (CIC) 评估其临床应用。根据独立预测因素绘制 Kaplan-Meier 生存曲线。多变量 Logistic 回归分析显示,ISR 组的红细胞分布宽度 (RDW) 高于非 ISR 组(比值比 (OR) = 1.54,95%置信区间 (CI):1.14-2.08,p < 0.01)。相反,最小支架直径与 ISR 呈负相关(OR = 0.28,95%CI:0.09-0.86,p = 0.03)。由这些显著特征组成的新型列线图呈现出 0.710 的一致性指数 (C-index),DCA 和 CIC 表明预测列线图具有临床实用性。Schoenfeld 残差表明,模型中 RDW≥12.6%且最小支架直径<3mm 与比例风险假设一致。ISR 的 Kaplan-Meier 估计显示具有统计学意义。较高的 RDW 水平和较低的最小支架直径与 DES 植入后老年 ACS 患者三年内 ISR 的发生率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8166/9208031/48d17e3f9901/10.1177_10760296221107888-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8166/9208031/2b6b77f0f8e2/10.1177_10760296221107888-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8166/9208031/b9e3f7d21d0a/10.1177_10760296221107888-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8166/9208031/ccec264a50dc/10.1177_10760296221107888-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8166/9208031/94f681f29cad/10.1177_10760296221107888-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8166/9208031/48d17e3f9901/10.1177_10760296221107888-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8166/9208031/2b6b77f0f8e2/10.1177_10760296221107888-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8166/9208031/b9e3f7d21d0a/10.1177_10760296221107888-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8166/9208031/ccec264a50dc/10.1177_10760296221107888-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8166/9208031/94f681f29cad/10.1177_10760296221107888-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8166/9208031/48d17e3f9901/10.1177_10760296221107888-fig5.jpg

相似文献

1
Predictive Value Analysis of in-Stent Restenosis Within Three Years in Older Acute Coronary Syndrome Patients: A Two-Center Retrospective Study.三年内老年急性冠状动脉综合征患者支架内再狭窄的预测价值分析:一项两中心回顾性研究。
Clin Appl Thromb Hemost. 2022 Jan-Dec;28:10760296221107888. doi: 10.1177/10760296221107888.
2
Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.红细胞分布宽度在预测稳定性心绞痛患者冠状动脉支架置入术后药物洗脱支架再狭窄中的作用
Coron Artery Dis. 2015 May;26(3):220-4. doi: 10.1097/MCA.0000000000000221.
3
Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.二代药物洗脱支架置入术后三血管病变患者血运重建和支架内再狭窄的危险因素:回顾性分析。
BMC Cardiovasc Disord. 2021 Sep 17;21(1):446. doi: 10.1186/s12872-021-02259-0.
4
Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.三酰甘油-葡萄糖指数与经皮冠状动脉介入治疗药物洗脱支架后急性冠状动脉综合征患者支架内再狭窄相关。
Cardiovasc Diabetol. 2021 Jul 8;20(1):137. doi: 10.1186/s12933-021-01332-4.
5
Systemic immune-inflammation index and in-stent restenosis in patients with acute coronary syndrome: a single-center retrospective study.系统免疫炎症指数与急性冠脉综合征患者支架内再狭窄:一项单中心回顾性研究。
Eur J Med Res. 2024 Feb 26;29(1):145. doi: 10.1186/s40001-024-01736-4.
6
Atherogenic Index of Plasma and the Risk of In-Stent Restenosis in Patients with Acute Coronary Syndrome beyond the Traditional Risk Factors.血浆致动脉粥样硬化指数与急性冠状动脉综合征患者支架内再狭窄风险:传统危险因素之外的因素。
J Atheroscler Thromb. 2022 Aug 1;29(8):1226-1235. doi: 10.5551/jat.63136. Epub 2021 Sep 9.
7
Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.依维莫司洗脱支架治疗药物洗脱支架与裸金属支架再狭窄的有效性。
Coron Artery Dis. 2012 Nov;23(7):492-6. doi: 10.1097/MCA.0b013e328358a58f.
8
Development and validation of a risk prediction nomogram for in-stent restenosis in patients undergoing percutaneous coronary intervention.经皮冠状动脉介入治疗患者支架内再狭窄风险预测列线图的建立与验证。
BMC Cardiovasc Disord. 2021 Sep 14;21(1):435. doi: 10.1186/s12872-021-02255-4.
9
Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations.三代支架时代冠状动脉支架内再狭窄的临床表现和结局。
Circ Cardiovasc Interv. 2014 Dec;7(6):768-76. doi: 10.1161/CIRCINTERVENTIONS.114.001341. Epub 2014 Dec 2.
10
Association of serum apoA-I with in-stent restenosis in coronary heart disease.血清载脂蛋白 A-I 与冠心病支架内再狭窄的相关性。
BMC Cardiovasc Disord. 2022 Aug 4;22(1):355. doi: 10.1186/s12872-022-02762-y.

引用本文的文献

1
A risk score for predicting in-stent restenosis in patients with premature acute myocardial infarction undergoing percutaneous coronary intervention with drug-eluting stent.预测接受药物洗脱支架经皮冠状动脉介入治疗的早发急性心肌梗死患者支架内再狭窄的风险评分。
Heliyon. 2024 Jul 4;10(13):e34077. doi: 10.1016/j.heliyon.2024.e34077. eCollection 2024 Jul 15.
2
A systematic review and bioinformatic study on clinical, paraclinical, and genetic factors predisposing to stent restenosis following percutaneous coronary intervention.经皮冠状动脉介入治疗后支架再狭窄的临床、辅助检查和遗传因素的系统评价和生物信息学研究。
BMC Cardiovasc Disord. 2024 Jun 14;24(1):304. doi: 10.1186/s12872-024-03955-3.
3

本文引用的文献

1
Incidence of Restenosis Following Rapamycin or Paclitaxeleluting Stent in Coronary Stent Implantation.雷帕霉素或紫杉醇洗脱支架置入冠状动脉后再狭窄发生率。
Cardiovasc Hematol Disord Drug Targets. 2021;21(3):196-201. doi: 10.2174/1871529X21666211209115126.
2
Risk factors for revascularization and in-stent restenosis in patients with triple-vessel disease after second-generation drug-eluting stent implantation: a retrospective analysis.二代药物洗脱支架置入术后三血管病变患者血运重建和支架内再狭窄的危险因素:回顾性分析。
BMC Cardiovasc Disord. 2021 Sep 17;21(1):446. doi: 10.1186/s12872-021-02259-0.
3
Coronary In-Stent Restenosis: Predictors and Treatment.
Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease.
冠心病患者冠状动脉药物洗脱支架初次植入后支架内再狭窄的风险调查
Front Cardiovasc Med. 2023 Mar 10;10:1117915. doi: 10.3389/fcvm.2023.1117915. eCollection 2023.
冠状动脉支架内再狭窄:预测因素与治疗。
Dtsch Arztebl Int. 2021 Sep 24;118(38):637-644. doi: 10.3238/arztebl.m2021.0254.
4
Association of Triglyceride Deposit Cardiomyovasculopathy With Drug-Eluting Stent Restenosis Among Patients With Diabetes.甘油三酯沉积性心肌病血管病与糖尿病患者药物洗脱支架再狭窄的相关性。
JAMA Netw Open. 2020 Aug 3;3(8):e2012583. doi: 10.1001/jamanetworkopen.2020.12583.
5
High red blood cell distribution width is closely associated with in-stent restenosis in patients with unstable angina pectoris.高红细胞分布宽度与不稳定型心绞痛患者支架内再狭窄密切相关。
BMC Cardiovasc Disord. 2019 Jul 24;19(1):175. doi: 10.1186/s12872-019-1159-3.
6
Association of high level of hs-CRP with in-stent restenosis: A case-control study.高敏C反应蛋白水平与支架内再狭窄的关联:一项病例对照研究。
Cardiovasc Revasc Med. 2019 Jul;20(7):583-587. doi: 10.1016/j.carrev.2018.08.015. Epub 2018 Aug 18.
7
Association of serum procalcitonin level with in-stent restenosis in patients undergoing bare-metal stent implantation.接受裸金属支架植入术患者血清降钙素原水平与支架内再狭窄的相关性
Biomark Med. 2018 May;12(5):455-463. doi: 10.2217/bmm-2017-0242. Epub 2018 Mar 8.
8
Balloon pin-hole rupture during percutaneous coronary intervention for recurrent, calcified in-stent restenosis: A case report.经皮冠状动脉介入治疗复发性钙化支架内再狭窄时球囊针孔破裂:一例报告
Catheter Cardiovasc Interv. 2018 Jun;91(7):1287-1290. doi: 10.1002/ccd.27405. Epub 2017 Nov 13.
9
Increased serum TREM-1 level is associated with in-stent restenosis, and activation of TREM-1 promotes inflammation, proliferation and migration in vascular smooth muscle cells.血清 TREM-1 水平升高与支架内再狭窄相关,TREM-1 的激活促进血管平滑肌细胞的炎症、增殖和迁移。
Atherosclerosis. 2017 Dec;267:10-18. doi: 10.1016/j.atherosclerosis.2017.10.015. Epub 2017 Oct 14.
10
Rehospitalizations Following Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction: Results From a Multi-Center Randomized Trial.ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗后的再住院情况:一项多中心随机试验的结果
J Am Heart Assoc. 2017 Aug 5;6(8):e005926. doi: 10.1161/JAHA.117.005926.